[ Tips ] 一分鐘使用導覽
商品編號： 9-698-010 出版日期： 1997/10/04 作者姓名： Thomke, Stefan;Pospisil, Paul;Nimgade, Ashok 商品類別： Operations management 商品規格： 25p 再版日期： 2003/09/02 地域： United States 產業： Chemical manufacturing;Pharmaceutical industry 個案年度： -
商品敘述：
Describes how Eli Lilly and Co. tries to accelerate its new drug development process with the aid of "combinatorial chemistry"--a rapidly emerging and revolutionary approach to preclinical drug discovery. The product manager of a potential blockbuster migraine drug faces the decision of "racing" the drug to market or spending additional time to refine an already promising drug candidate. Focuses on: (1) the new drug development process with an emphasis on pre-clinical drug discovery; (2) radical innovations ("combinatorial chemistry") in the drug discovery process; (3) the managerial challenges of introducing such innovations into a large organization with multiple stakeholders; (4) the financial value of time-to-market; and (5) the changing competitive environment in the pharmaceutical industry.
涵蓋領域：
Stakeholder relations;Finance and investing;Process management;Organizational change;Product development;Innovation;Competitive strategy;Operations strategy;Digital transformation
相關資料：
, (9-698-033), 21p, by Stefan Thomke, Ashok Nimgade
哪些人也有訂購？